Cardiol Therapeutics Inc (CRDL)
1.79
+0.01
(+0.56%)
USD |
NASDAQ |
Apr 23, 09:39
Cardiol Therapeutics Total Liabilities (Quarterly): 6.373M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 6.373M |
| September 30, 2023 | 6.020M |
| June 30, 2023 | 6.353M |
| March 31, 2023 | 5.271M |
| December 31, 2022 | 7.241M |
| September 30, 2022 | 7.079M |
| June 30, 2022 | 8.858M |
| March 31, 2022 | 8.185M |
| December 31, 2021 | 9.128M |
| September 30, 2021 | 2.075M |
| June 30, 2021 | 2.429M |
| March 31, 2021 | 2.265M |
| Date | Value |
|---|---|
| December 31, 2020 | 2.057M |
| September 30, 2020 | 1.481M |
| June 30, 2020 | 0.9622M |
| March 31, 2020 | 0.5827M |
| December 31, 2019 | 0.636M |
| September 30, 2019 | 1.253M |
| June 30, 2019 | 0.7237M |
| March 31, 2019 | 0.7316M |
| December 31, 2018 | 1.770M |
| September 30, 2018 | 12.62M |
| December 31, 2017 | 0.2917M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
0.5827M
Minimum
Mar 2020
9.128M
Maximum
Dec 2021
4.156M
Average
2.429M
Median
Jun 2021
Total Liabilities (Quarterly) Benchmarks
| Aurinia Pharmaceuticals Inc | 170.11M |
| Acasti Pharma Inc | 11.50M |
| Edesa Biotech Inc | 1.987M |
| Lexaria Bioscience Corp | 0.2042M |
| Xenon Pharmaceuticals Inc | 36.88M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 27.67M |
| Shareholders Equity (Quarterly) | 21.29M |